Dearborn Partners LLC cut its position in Bristol-Myers Squibb ( NYSE:BMY – Free Report ) by 15.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,034 shares of the biopharmaceutical company's stock after selling 1,500 shares during the period. Dearborn Partners LLC's holdings in Bristol-Myers Squibb were worth $557,000 as of its most recent filing with the Securities and Exchange Commission. A number of other large investors also recently modified their holdings of the company.

https://www.dailypolitical.com/2023/08/01/dearborn-partners-llc-reduces-position-in-bristol-myers-squibb-nysebmy.html

#dailypolitical